Prediction: These 5 Stocks Will Be the Best Performers of 2026

Key numbers: Broadcom projects its custom AI chips will generate >$100B in annual sales by end-2027 (its AI division produced $8.4B in the latest quarter); Nvidia trades at ~20.2x forward EPS; TSMC expects ~25% revenue CAGR 2024–2029; Nebius guides ARR from $1.25B (end-2025) to $7–9B (end-2026). The author recommends buying Broadcom, Nvidia, Microsoft, TSMC and Nebius as AI-driven recovery plays and cites attractive valuations and large addressable spend on AI. Recommendation is bullish but execution- and geopolitics-dependent (mentions potential upside if Iran conflict resolves) and relies on companies meeting aggressive growth guidance.

Analysis

Broadcom's AI chip ramp is a classic second-order demand-creation story: if customers diversify away from a single vendor, the immediate winners are not only the new chip vendor but the foundry, packaging and precision‑metrology suppliers that enable heterogeneous stacks. That dynamics favors capital‑intensive suppliers with constrained near‑term capacity (foundries, advanced packaging, EUV tool vendors), which can support a multi‑quarter pricing cycle even if ASPs for compute bricks begin to compress.

Key risks cluster around capacity and architecture risk rather than pure end‑demand. An inventory hangover at hyperscalers or a faster-than‑expected shift to model compression/edge inference could shave 20–40% off incremental data‑center chip orders inside 12–24 months; conversely, aggressive pricing by new entrants could accelerate share shifts but depress margins across the stack. Geopolitical policy (export controls or regional capex incentives) remains a 3–18 month catalyst that can reallocate tens of billions of capex between suppliers and reshape relative winners.

Consensus is underweight execution risk at small, high‑growth cloud suppliers and overweights headline incumbents without accounting for margin cycle and capital intensity. That creates practical tradeable asymmetries: buy optionality on execution-heavy, high-upside small caps with tight position sizing, overweight foundry/packaging exposure for a multi‑quarter cyclical run, and hedge the tail of a sentiment unwind with short‑dated protection on the largest single‑name exposures.

Key Decisions for Investors

• TSM (overweight, 12–18 months): Size at 2–4% of portfolio. Objective: capture foundry re‑rate if multi‑year AI capex continues; target +25–35% upside in 12–18 months, hard stop -12%. Hedge with 1% portfolio buy of 6–9 month puts if realized volatility spikes above 40%.
• AVGO vs NVDA pair (relative play, 3–9 months): Go long Broadcom equal‑dollar and short Nvidia notional to neutralize market beta — size pair at 1–2% net portfolio risk. Rationale: asymmetry from Broadcom’s lower market expectations and potential share gains; reward if AVGO outperforms NVDA by >15% over the trade window. Use collars (sell OTM calls on long AVGO / buy OTM calls on short NVDA) to cap tail risk if NVDA gaps higher.
• NBIS (high‑conviction, binary, 12–18 months): Allocate 0.5–1% of portfolio to long‑dated call LEAPS or equity (strict stop). Expect 3x+ upside on successful enterprise deals/execution; accept 100% downside if guidance misses. Layer position on near‑term revenue confirmations (customer SLAs or published ARR beats).
• Protective hedges (insurance, 3–6 months): Buy 3–6 month puts on the largest concentrated AI exposure (NVDA or etf proxy) sized to cover 30–40% of notional exposure. Cost is insurance against a sentiment shock or a guidance‑driven rerating; treat as tactical expense when portfolio NVDA >5%.